Mayumi Nagashimada

3.2k citations

35 papers · 2.6k indexed · 1 hit paper · h-index 26

Endocrinology, Diabetes and Metabolism top 2%
- Diet, Metabolism, and Disease 8
Biochemistry top 2%
Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 18
- Adipokines, Inflammation, and Metabolic Diseases 7
Hepatology top 5%
- Liver Disease and Transplantation 3
Gastroenterology top 5%
Physiology
- Adipose Tissue and Metabolism 7
Surgery
- Congenital gastrointestinal and neural anomalies 5
Molecular Biology
- Genomics, phytochemicals, and oxidative stress 4
Cardiology and Cardiovascular Medicine
- Lipid metabolism and disorders 3

Co-authors: Tsuguhito Ota Yinhua Ni Shuichi Kaneko Fen Zhuge Naoto Nagata Toshihiro Uesaka Hideki Enomoto Liang Xu
Cited by: Endocrinology, Diabetes and Metabolism Biochemistry Epidemiology
Journals: Journal of Clinical Investigation (2 papers)Journal of Neuroscience (2 papers)PLoS ONE (1 paper)
Partner nations: Japan China United States

In The Last Decade

Mayumi Nagashimada

35 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Mayumi Nagashimada

Since Specialization

Citations

This map shows the geographic impact of Mayumi Nagashimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayumi Nagashimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayumi Nagashimada more than expected).

Fields of papers citing papers by Mayumi Nagashimada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayumi Nagashimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayumi Nagashimada. The network helps show where Mayumi Nagashimada may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mayumi Nagashimada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mayumi Nagashimada Line = papers co-authored together Mayumi Nagashimada links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cenicriviroc Suppresses and Reverses Steatohepatitis by Regulating Macrophage Infiltration and M2 Polarization in Mice Endocrinology ·Guanliang Chen,Yanwen Yu,Yuqin Zhu,Mayumi Nagashimada,Yajiao Wang,Naoto Nagata,Liang Xu	2024	2
2	A natural Nrf2 activator glucoraphanin improves hepatic steatosis in high-fat diet-induced obese male mice associated with AMPK activation Diabetology International ·Suratsawadee Promsuwan,Kazuki Sawamoto,Liang Xu,Mayumi Nagashimada,Naoto Nagata,Yumi Takiyama	2023	2
3	CX3CL1/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1/M2 status Metabolism ·Yinhua Ni,Fen Zhuge,Liyang Ni,Naoto Nagata,Tatsuya Yamashita,Naofumi Mukaida,Shuichi Kaneko,Tsuguhito Ota,Mayumi Nagashimada	2022	52
4	LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH Scientific Reports ·Noboru Takata,Kiyo‐aki Ishii,Hiroaki Takayama,Mayumi Nagashimada,Kyoko Kamoshita,Takeo Tanaka,Akihiro Kikuchi,Yumie Takeshita,Yukako Matsumoto,Tsuguhito Ota,Yasuhiko Yamamoto,Satoshi Yamagoe,Akihiro Seki,Yoshio Sakai,Shuichi Kaneko,Toshinari Takamura	2021	41
5	C C chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice Metabolism ·Liang Xu,Yong‐Ping Chen,Mayumi Nagashimada,Yinhua Ni,Fen Zhuge,Guanliang Chen,Haoran Li,Tongtong Pan,Tatsuya Yamashita,Naofumi Mukaida,Shuichi Kaneko,Tsuguhito Ota,Naoto Nagata	2021	56
6	Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice Scientific Reports ·Tomoki Nishikawa,Naoto Nagata,Tetsuro Shimakami,Takashi Shirakura,Chieko Matsui,Yinhua Ni,Fen Zhuge,Liang Xu,Guanliang Chen,Mayumi Nagashimada,Taro Yamashita,Yoshio Sakai,Tatsuya Yamashita,Eishiro Mizukoshi,Masao Honda,Shuichi Kaneko,Tsuguhito Ota	2020	57
7	Lycopene prevents the progression of lipotoxicity-induced nonalcoholic steatohepatitis by decreasing oxidative stress in mice Free Radical Biology and Medicine ·Yinhua Ni,Fen Zhuge,Mayumi Nagashimada,Naoto Nagata,Liang Xu,Sayo Yamamoto,Nobuo Fuke,Yusuke Ushida,Hiroyuki Suganuma,Shuichi Kaneko,Tsuguhito Ota	2019	53
8	Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages Laboratory Investigation ·Guanliang Chen,Yinhua Ni,Naoto Nagata,Liang Xu,Fen Zhuge,Mayumi Nagashimada,Shuichi Kaneko,Tsuguhito Ota	2019	29
9	SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Micebreakdown → EBioMedicine ·Liang Xu,Naoto Nagata,Mayumi Nagashimada,Fen Zhuge,Yinhua Ni,Guanliang Chen,Eric Mayoux,Shuichi Kaneko,Tsuguhito Ota	2017	402
10	Central Insulin Action Activates Kupffer Cells by Suppressing Hepatic Vagal Activation via the Nicotinic Alpha 7 Acetylcholine Receptor Cell Reports ·Kumi Kimura,Mamoru Tanida,Naoto Nagata,Y. Inaba,Hitoshi Watanabe,Mayumi Nagashimada,Tsuguhito Ota,Shun‐ichiro Asahara,Yoshiaki Kido,Michihiro Matsumoto,Koji Toshinai,Masamitsu Nakazato,Toshishige Shibamoto,Shuichi Kaneko,Masato Kasuga,Hiroshi Inoue	2016	67
11	Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis Nutrients ·Yinhua Ni,Fen Zhuge,Mayumi Nagashimada,Tsuguhito Ota	2016	73
12	Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E Scientific Reports ·Yinhua Ni,Mayumi Nagashimada,Fen Zhuge,Lili Zhan,Naoto Nagata,Akemi Tsutsui,Yasuni Nakanuma,Shuichi Kaneko,Tsuguhito Ota	2015	212
13	Neuronal Differentiation in Schwann Cell Lineage Underlies Postnatal Neurogenesis in the Enteric Nervous System Journal of Neuroscience ·Toshihiro Uesaka,Mayumi Nagashimada,Hideki Enomoto	2015	173
14	β-Cryptoxanthin Alleviates Diet-Induced Nonalcoholic Steatohepatitis by Suppressing Inflammatory Gene Expression in Mice PLoS ONE ·Masuko Kobori,Yinhua Ni,Yumiko Takahashi,Natsumi Watanabe,Minoru Sugiura,Kazunori Ogawa,Mayumi Nagashimada,Shuichi Kaneko,Shigehiro Naito,T. Ota	2014	63
15	GDNF Signaling Levels Control Migration and Neuronal Differentiation of Enteric Ganglion Precursors Journal of Neuroscience ·Toshihiro Uesaka,Mayumi Nagashimada,Hideki Enomoto	2013	65
16	CCR5はマクロファージ動員とM1/M2状態を調節することで,肥満による脂肪組織の炎症およびインスリン抵抗性に重要な役割を果たす Diabetes ·Hironori Kitade,Kazuki Sawamoto,Mayumi Nagashimada	2013	1
17	CCR5 Plays a Critical Role in Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance by Regulating Both Macrophage Recruitment and M1/M2 Status Diabetes ·Hironori Kitade,Kazuki Sawamoto,Mayumi Nagashimada,Hiroshi Inoue,Yasuhiko Yamamoto,Yoshimichi Sai,Toshinari Takamura,Hiroshi Yamamoto,Ken‐ichi Miyamoto,Henry N. Ginsberg,Naofumi Mukaida,Shuichi Kaneko,Tsuguhito Ota	2012	240
18	Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expression Journal of Clinical Investigation ·Mayumi Nagashimada,Hiroshi Ohta,Chong Li,Kazuki Nakao,Toshihiro Uesaka,Jean‐François Brunet,Jeanne Amiel,Delphine Trochet,Teruhiko Wakayama,Hideki Enomoto	2012	83
19	Diminished Ret expression compromises neuronal survival in the colon and causes intestinal aganglionosis in mice Journal of Clinical Investigation ·Toshihiro Uesaka,Mayumi Nagashimada,Shigenobu Yonemura,Hideki Enomoto	2008	132
20	Differential gene expression and functional analysis implicate novel mechanisms in enteric nervous system precursor migration and neuritogenesis Developmental Biology ·Bhupinder P. S. Vohra,Keiji Tsuji,Mayumi Nagashimada,Toshihiro Uesaka,Daniel Wind,Ming Fu,Jennifer L. Armon,Hideki Enomoto,Robert O. Heuckeroth	2006	56

About Mayumi Nagashimada

Mayumi Nagashimada is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Hepatology, having authored 35 papers that have together received 2.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (18 papers), Diet, Metabolism, and Disease (8 papers), Adipose Tissue and Metabolism (7 papers), Adipokines, Inflammation, and Metabolic Diseases (7 papers), Congenital gastrointestinal and neural anomalies (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Liver Disease and Transplantation (3 papers) and Lipid metabolism and disorders (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (602 citations), Biochemistry (203 citations) and Epidemiology (962 citations). Mayumi Nagashimada has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Tsuguhito Ota, Yinhua Ni, Shuichi Kaneko, Fen Zhuge, Naoto Nagata, Toshihiro Uesaka, Hideki Enomoto, Liang Xu, Guanliang Chen and Naofumi Mukaida. Their work appears in journals such as Journal of Clinical Investigation, Journal of Neuroscience and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact